Body composition in preterm infants who are fed long-chain polyunsaturated fatty acids: a prospective, randomized,

Sharon Groh-Wargo1, Joan Jacobs, Nancy Auestad

  • 1Department of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, Ohio 44109, USA. sgrohwargo@metrohealth.org

Pediatric Research
|February 19, 2005
PubMed

Insights

Supplementing preterm infant formula with arachidonic acid (ARA) and docosahexaenoic acid (DHA) to 1 year corrected age improved body composition. Infants showed increased lean body mass and reduced fat mass, supporting normal growth.

Area of Science:

  • * Nutritional Science
  • * Pediatric Nutrition
  • * Human Physiology

Background:

  • * Premature infants (<33 wk gestation) require specialized nutrition for optimal growth and development.
  • * Docosahexaenoic acid (DHA) and arachidonic acid (ARA) are crucial fatty acids for infant neurodevelopment and overall growth.
  • * Optimal levels and sources of DHA and ARA in preterm formulas are still under investigation.

Purpose of the Study:

  • * To assess the impact of DHA and ARA supplementation in preterm formulas on growth and body composition up to 1 year of corrected age.
  • * To compare the effects of different DHA+ARA sources (fish/fungal oil vs. egg/fish oil) on preterm infant development.
  • * To evaluate the long-term effects of DHA and ARA on body composition, including lean body mass and fat mass.

Main Methods:

  • * A randomized controlled trial involving preterm infants (750-1800 g birth weight, <33 wk gestation).
  • * Infants were fed one of three formulas: control, DHA+ARA from fish/fungal oil, or DHA+ARA from egg/fish oil.
  • * Body composition was assessed using dual-energy x-ray absorptiometry at various time points up to 12 months corrected age.

Main Results:

  • * No significant differences in weight, length, or head circumference were observed among the groups.
  • * Bone mineral content and density were comparable across all study groups.
  • * Infants fed DHA+ARA-supplemented formulas exhibited significantly greater lean body mass and lower fat mass at 12 months corrected age compared to controls.

Conclusions:

  • * DHA and ARA supplementation in preterm formulas supports normal growth and bone mineralization in preterm infants.
  • * Supplementation with DHA and ARA to 1 year corrected age positively influences body composition, increasing lean mass and decreasing fat mass.
  • * Preterm formulas with specific levels and ratios of DHA and ARA can be effectively used to optimize body composition in premature infants.

Related Concept Videos